During the call, members of the NeOnc management team and independent members of the Company’s Scientific Advisory Board (SAB) will present initial data from the Phase 1 dose-escalation portion of the ...

Connecticut’s legal market is artificially constrained by a limitation that neither improves safety nor reflects how cannabis ...

Minor changes in moisture level can promote lipid molecules to reorganize themselves in biomaterial or biomembranes. This can affect how the skin, lungs and tear film protect us from dehydration. This ...

CEOCFO interviews NanOlogy, LLC CEO David J. Arthur on Solving Toxicity & Bioavailability Problems when Treating ...

The use of acidic MPAs (pH 2–4) is the default in pharmaceutical testing because they suppress silanol ionization (from Si-OH to Si-O -) and improve peak shape for basic drugs. However, highly ...

NRx Pharmaceuticals, Inc. (NASDAQ: NRXP), a clinical-stage biopharmaceutical company developing therapeutics based on its NMDA platform for the treatment of central nervous system (CNS) disorders, ...

As GLP-1 adoption reshapes appetite, satiety, and purchasing patterns, food and beverage manufacturers are reassessing formulation strategies. In this Q&A, Tate & Lyle’s Jenna Peterson discusses ...

The FDA recently revised its approach to beverage labels in terms of artificial colors, while also approving two new natural color solutions. Kathleen Sanzo with Morgan Lewis details how this will ...

How integrated pharmaceutical manufacturing helps CDMOs simplify scale-up, reduce complexity, and move from raw materials to finished dosage forms faster.

The company’s focus on user satisfaction is highlighted by its 60-day guarantee on the full product line, which allows customers to try products risk-free. All R&R products are certified USDA organic, ...

Management's guidance language shifted from a general $4 billion revenue target by 2027 in Q3 to a more aggressive "double down" commitment to reaching the run rate by the end of 2026, not requiring ...

Following the launch of its Wegovy (semaglutide) pill at the beginning of the year, Novo Nordisk is committing as much as ...